Physician profile
John Bachmann
NPI 1750004065
$2,314.15
in general payments reported to CMS, 2019-2025
21 companies · $633 in 2025
The $633 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $863 · 2024: $679 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $582.89 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $434.58 | 2022-2025 | |
| Janssen Biotech, INC. | $333.11 | 2023-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $140.99 | 2023-2025 | Xtandi, Padcev |
| Myriad Genetic Laboratories, INC. | $137.45 | 2023 | Prolaris |
| Abbvie INC. | $106.55 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $99.95 | 2022-2024 | Pylarify |
| Dendreon Pharmaceuticals LLC | $99.87 | 2023-2024 | Provenge |
| Endo USA, INC. | $49.58 | 2025 | Aveed, Xiaflex |
| 180 Medical, INC. | $42.60 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Pfizer INC. | $38.77 | 2023-2025 | |
| Urogen Pharma, INC. | $36.22 | 2022-2023 | Jelmyto |
| Urovant Sciences INC | $32.86 | 2022 | |
| Procept Biorobotics Corporation | $29.39 | 2024 | Aquabeam System |
| Ambu INC. | $28.47 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $24.95 | 2023 | |
| Hologic Sales and Service, LLC | $22.68 | 2025 | Aptima |
| Tolmar, INC. | $21.11 | 2025 | Eligard, Jatenzo |
| Olympus America INC. | $20.11 | 2023 | Itind System |
| Mission Pharmacal Company | $16.22 | 2022 | |
| Axonics, INC. | $15.80 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bachmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.